Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 1 March

Sam Kanaan
March 1, 2024

Morning Bell 29 February

Sam Kanaan
February 29, 2024

Morning Bell 28 February

Grady Wulff
February 28, 2024

Morning Bell 27 February

Grady Wulff
February 27, 2024

Morning Bell 26 February

Grady Wulff
February 26, 2024

Weekly Wrap 23 February

Grady Wulff
February 23, 2024

Morning Bell 22 February

Sam Kanaan
February 22, 2024

Morning Bell 21 February

Grady Wulff
February 21, 2024

Morning Bell 20 February

Grady Wulff
February 20, 2024

Morning Bell 19 February

Grady Wulff
February 19, 2024